Estamos realizando la búsqueda. Por favor, espere...

 Detalle_Publicacion

Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies

Abstract: The management of diffuse supratentorial WHO grade II glioma remains a challenge because of the infiltrative nature of the tumor, which precludes curative therapy after total or even supratotal resection. When possible, functional-guided resection is the preferred initial treatment. Total and subtotal resections correlate with increased overall survival. High-risk patients (age[40, partial resection), especially IDH-mutated and 1p19qcodeleted oligodendroglial lesions, benefit from surgery plus adjuvant chemoradiation. Under the new 2016 WHO brain tumor classification, which now incorporates molecular parameters, all diffusely infiltrating gliomas are grouped together since they share specific genetic mutations and prognostic factors. Although low-grade gliomas cannot be regarded as benign tumors, large observational studies have shown that median survival can actually be doubled if an early, aggressive, multi-stage and personalized therapy is applied, as compared to prior wait-and-see policy series. Patients need an honest long-term therapeutic strategy that should ideally anticipate neurological, cognitive and histopathologic worsening.

 Fuente: Clin Transl Oncol. 2017 Aug; 19(8):931-944

Editorial: Springer-Verlag Italia

 Año de publicación: 2017

Nº de páginas: 14

Tipo de publicación: Artículo de Revista

 DOI: 10.1007/s12094-017-1631-4

ISSN: 1699-048X,1699-3055

Autores/as

DELGADO LÓPEZ, P.D.

CORRALES GARCÍA, E.M.

LASTRA ARAS, E.

DUEÑAS POLO, M.T.